The increased prevalence, severity, and complications of type 2 diabetes in COVID-19 patients may be related to human angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 receptors, which are expressed on pancreatic beta cells (11). Here, ACE2 is linked to COVID-19.